sunitinib
crenolanib
sitravatinib
bosutinib
bosatinib
lorlatinib
axitinib
mobocertinib
neratinib
erdafitinib
-tinib
dovitinib
telatinib
dasatinib
tepotinib
sorafenib
cediranib
lestaurtinib
tandutinib
ibrutinib
anlotinib
belzutifan
temsirolimus
gilteritinib
cabozantinib
fluorouracil
pelitinib
avapritinib
immunokinase
ribociclib
nephrocarcinoma
omacetaxine
linifanib
ripretinib
hypernephroma
necitumumab
tisagenlecleucel
gastroadenocarcinoma
oncotropic
osimertinib
dacarbazine
futibatinib
TNF inhibitor
mirvetuximab soravtansine
saracatinib
vintafolide
malhamensilipin
capecitabine
ivosidenib
CD117
pamrevlumab
malignoma
cinacalcet
fostamatinib
bortezomib
galunisertib
HER-2
entospletinib
folliculin
nephroma
bevacizumab
hepzidine
periwinkle plant derivative
gastrinoma
antivascular
fadrozole
tivozanib
antianaplastic
picoplatin
amonafide
ebrotidine
melphalan
argentaffinoma
Alkeran
adecatumumab
thiotepa
angioarrestin
loxtidine
acasunlimab
antithrombolytic
carcinosarcoma
folinic acid
daurinol
deazaneplanocin
gefitinib
paullone
ceritinib
angiotensin-converting enzyme inhibitor
trastuzumab
ubenimex
palbociclib
-nercept
aprinocarsen
alisertib
mubritinib
melphalan flufenamide
gastrocarcinoma
ACE inhibitor
migrastatic
angiogenesis inhibitor